# RABEPRAZOLE SODIUM

NDC: 68788-8536
Generic name: rabeprazole sodium
Labeler / Manufacturer: Preferred Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20231019

FDA application: ANDA204237

## Active ingredients

- RABEPRAZOLE SODIUM: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68788-8536"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68788-8536
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4582d443-f1be-4f94-85da-49aa603f54e4